Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,219 public trials 2,045 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

NCT00680901

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +11 more
Locations
  • Novartis Investigative Site Alhambra, California, United States
  • Novartis Investigative Site Fullerton, California, United States
  • Novartis Investigative Site La Verne, California, United States
  • Novartis Investigative Site Northridge, California, United States
View all 183 locations
View Trial Details
Completed

Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery

NCT04311099

Conditions
Abdominal Pain, Agnosia, Analgesia, +26 more
Locations
  • Sydvestjysk Sygehus Esbjerg, Denmark
  • Regionshospitalet Herning Herning, Denmark
  • Copenhagen University Hospital - North Zealand Hillerød, Denmark
  • Copenhagen University Hospital - Hvidovre Hvidovre, Denmark
View Trial Details
Completed

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

NCT02872116

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Local Institution - 0005 Los Angeles, California, United States
  • Local Institution - 0001 San Francisco, California, United States
  • Local Institution - 0066 Aurora, Colorado, United States
  • Local Institution - 0151 Denver, Colorado, United States
View all 179 locations
View Trial Details
Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

NCT02903914

Conditions
Adenocarcinoma, Adenoma, Bladder Cancer, +49 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Honor Health/Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Georgetown Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab

NCT02013154

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, Carcinoma, Squamous Cell, +15 more
Locations
  • Cedars Sinai Medical Care Foundation Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Phase 2 Study of DKN-01 in Colorectal Cancer

NCT05480306

Conditions
Colo-rectal Cancer, Colonic Diseases, Colonic Neoplasms, +13 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute (FCS) Cape Coral, Florida, United States
  • Florida Cancer Specialists & Research Institute Fleming Island, Florida, United States
View all 40 locations
View Trial Details

Related conditions